vs
Side-by-side financial comparison of Nano Labs Ltd (NA) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.
Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $2.7M, roughly 1.8× Nano Labs Ltd). Nano Labs Ltd runs the higher net margin — 754.5% vs -961.9%, a 1716.4% gap on every dollar of revenue.
Weebit Nano is a public semiconductor IP company founded in Israel in 2015 and headquartered in Hod HaSharon, Israel. The company develops Resistive Random-Access Memory technologies. Resistive Random-Access Memory is a specialized form of non-volatile memory (NVM) for the semiconductor industry. The company's products are targeted at a broad range of NVM markets where persistence, performance, and endurance are all required. ReRAM technology can be integrated in electronic devices like weara...
Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.
NA vs SCLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $4.8M |
| Net Profit | $20.3M | $-46.1M |
| Gross Margin | — | 45.5% |
| Operating Margin | — | -2317.8% |
| Net Margin | 754.5% | -961.9% |
| Revenue YoY | — | -67.8% |
| Net Profit YoY | — | -613.7% |
| EPS (diluted) | $1.03 | $-4.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $4.8M | ||
| Q3 25 | — | $10.6M | ||
| Q2 25 | $1.2M | $9.9M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $14.9M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | $3.5M | $16.4M | ||
| Q1 24 | — | $10.9M |
| Q4 25 | $20.3M | $-46.1M | ||
| Q3 25 | — | $-257.8M | ||
| Q2 25 | $-985.5K | $-44.0M | ||
| Q1 25 | — | $-26.1M | ||
| Q4 24 | — | $-6.5M | ||
| Q3 24 | — | $-4.4M | ||
| Q2 24 | $-8.0M | $-37.6M | ||
| Q1 24 | — | $-24.4M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 68.5% | ||
| Q2 25 | — | 66.9% | ||
| Q1 25 | — | 72.3% | ||
| Q4 24 | — | 68.5% | ||
| Q3 24 | — | 73.9% | ||
| Q2 24 | 0.1% | 73.2% | ||
| Q1 24 | — | 64.7% |
| Q4 25 | — | -2317.8% | ||
| Q3 25 | — | -1766.2% | ||
| Q2 25 | -459.2% | -207.2% | ||
| Q1 25 | — | -557.5% | ||
| Q4 24 | — | -190.5% | ||
| Q3 24 | — | -138.0% | ||
| Q2 24 | -237.2% | -95.4% | ||
| Q1 24 | — | -179.0% |
| Q4 25 | 754.5% | -961.9% | ||
| Q3 25 | — | -2441.5% | ||
| Q2 25 | -85.2% | -445.1% | ||
| Q1 25 | — | -521.2% | ||
| Q4 24 | — | -43.4% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | -231.3% | -229.6% | ||
| Q1 24 | — | -224.0% |
| Q4 25 | $1.03 | $-4.63 | ||
| Q3 25 | — | $-22.17 | ||
| Q2 25 | $-0.06 | $-7.42 | ||
| Q1 25 | — | $-2.26 | ||
| Q4 24 | — | $8.53 | ||
| Q3 24 | — | $-0.58 | ||
| Q2 24 | $-0.12 | $-7.67 | ||
| Q1 24 | — | $-8.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $5.0M |
| Total DebtLower is stronger | $24.5M | — |
| Stockholders' EquityBook value | $106.5M | $-207.8M |
| Total Assets | $159.3M | $365.0M |
| Debt / EquityLower = less leverage | 0.23× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $5.0M | ||
| Q3 25 | — | $878.0K | ||
| Q2 25 | $50.8M | $4.1M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $77.0K | ||
| Q2 24 | $3.3M | $6.9M | ||
| Q1 24 | — | $1.8M |
| Q4 25 | $24.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $24.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $22.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | $106.5M | $-207.8M | ||
| Q3 25 | — | $-176.9M | ||
| Q2 25 | $86.8M | $-249.0M | ||
| Q1 25 | — | $-211.5M | ||
| Q4 24 | — | $-192.6M | ||
| Q3 24 | — | $-211.3M | ||
| Q2 24 | $-5.1M | $-214.7M | ||
| Q1 24 | — | $-189.8M |
| Q4 25 | $159.3M | $365.0M | ||
| Q3 25 | — | $275.9M | ||
| Q2 25 | $206.4M | $83.8M | ||
| Q1 25 | — | $79.0M | ||
| Q4 24 | — | $93.0M | ||
| Q3 24 | — | $100.4M | ||
| Q2 24 | $51.2M | $104.5M | ||
| Q1 24 | — | $91.2M |
| Q4 25 | 0.23× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.3M | $-17.5M |
| Free Cash FlowOCF − Capex | $-8.4M | — |
| FCF MarginFCF / Revenue | -312.3% | — |
| Capex IntensityCapex / Revenue | 2.9% | — |
| Cash ConversionOCF / Net Profit | -0.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.3M | $-17.5M | ||
| Q3 25 | — | $8.2M | ||
| Q2 25 | $-7.1M | $7.0M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | $-10.8M | $2.3M | ||
| Q1 24 | — | $9.4M |
| Q4 25 | $-8.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-15.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | -312.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -620.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -443.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 133.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
